Recruiting
Acupuncture Therapy and Hypertension
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
ClinicalTrials.gov IDNCT05530512
PhaseNA
Enrollment72
SponsorUniversity of California, Irvine
Age45 Years
SexALL
Conditions studied
Mild to Moderate Hypertension
About this study
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
Interventions
- Other: electroacupuncture — acupuncture needling and stimulation are applied for 30 min
Primary outcomes
- Changes in sympathetic and parasympathetic nervous systems (through study completion, an average of 4.5 years)
Eligibility information
Inclusion Criteria:
1. Subjects from 45 to 75 years of age
2. Clinically diagnosed with mild to moderate hypertension and ON or OFF medication (Office SBP \> 140 mmHg and \< 160 mmHg Or ABPM average SBP \> 130 mmHg and \< 145 mmHg), and
3. No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study.
Exclusion Criteria:
1. Subjects will be excluded if pregnant or nursing.
2. Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (\<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP \>170 mmHg systolic or \>110 mmHg diastolic), or any other physical or psychological illness.
3. Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded.
4. Inability our or unwillingness of individual to give written informed consent.
Study locations
- Susan Samueli Integrative Health Institute, Irvine, California 92697 United States
- University of California, Irvine, Health Sciences Medical Center, Orange, California 92868 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.